Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04380246 · ClinicalTrials.gov registry record
COA-APTIC Clinician Concept Elicitation Study
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 27
- Enrollment target
NCT04380246: Completed study, sponsored by Duke University.
NCT04380246 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04380246 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
This is a concept elicitation study to identify important aspects of acute pain assessment, treatment, and response to treatment in infants and young children, age 0 to 3 years old, from a clinician's perspective.
Primary Outcome
A 1-hour qualitative interview will be conducted and transcript or interviewer notes coded to assess how clinicians identify and recognize acute pain in infants and young children
Interventions
- OTHER Qualitative Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2020-08-06 |
| Est. Completion | 2020-12-21 |
What the finished NCT04380246 record still lists
NCT04380246 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Qualitative Interview is the first listed.
NCT04380246 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04380246 about?
NCT04380246 is a clinical study titled "COA-APTIC Clinician Concept Elicitation Study". This is a concept elicitation study to identify important aspects of acute pain assessment, treatment, and response to treatment in infants and young children, age 0 to 3 years old, from a clinician's perspective.
What is the current status of trial NCT04380246?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2020-08-06. Estimated completion is 2020-12-21.
What interventions are being tested in trial NCT04380246?
The interventions under investigation include: Qualitative Interview (OTHER).
Who is sponsoring clinical trial NCT04380246?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI